Cargando…
A prospective head-to-head comparison of [(68)Ga]Ga-P16-093 and [(68)Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
PURPOSE: We aimed to compare the diagnostic performance and biodistribution of two similar PET agents, [(68)Ga]Ga-P16-093 and [(68)Ga]Ga-PSMA-11, in the same group of primary prostate cancer (PCa) patients. METHODS: Fifty patients with untreated, histologically confirmed PCa by needle biopsy were en...
Autores principales: | Wang, Guochang, Li, Linlin, Zhu, Ming, Zang, Jie, Wang, Jiarou, Wang, Rongxi, Yan, Weigang, Zhu, Lin, Kung, Hank F., Zhu, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213584/ https://www.ncbi.nlm.nih.gov/pubmed/37233785 http://dx.doi.org/10.1007/s00259-023-06283-4 |
Ejemplares similares
-
Dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study
por: Wang, Rongxi, et al.
Publicado: (2023) -
Cyclotron-based production of (68)Ga, [(68)Ga]GaCl(3), and [(68)Ga]Ga-PSMA-11 from a liquid target
por: Rodnick, Melissa E., et al.
Publicado: (2020) -
[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021) -
Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020) -
Musculoskeletal pitfalls in (68)Ga-PSMA
PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)